{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:09:22Z","timestamp":1774616962744,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009915","name":"Mbarara University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07707-8","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:35:03Z","timestamp":1771616103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between non-high-density lipoprotein cholesterol and non-alcoholic fatty liver disease among people living with HIV on dolutegravir-based antiretroviral therapy: A cross-sectional study in Southwestern Uganda"],"prefix":"10.1186","volume":"19","author":[{"given":"Charles Nkubi","family":"Bagenda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Nantongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elastus","family":"Ssemwanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Junior","family":"Mugisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesca Wafwoyo","family":"Akoth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nzaramba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogers","family":"Kalyetsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazira","family":"Tumusiime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blendar","family":"Ainebyoona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadrach","family":"Omara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Mwesigye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia Achieng","family":"Lumumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad","family":"Lubwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson","family":"Musinguzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Ampaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Nassali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Itabangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence Obado","family":"Osuwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Ssenkumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald Ouma","family":"Omolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"7707_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"E Easl","year":"2016","unstructured":"EASL E. EASO. European association for the study of the liver (EASL)-European association for the study of diabetes (EASD)-European association for the study of obesity (EASO): clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59:1121\u201340.","journal-title":"Diabetologia"},{"key":"7707_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong V-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"7707_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10455-y","volume":"25","author":"J Wei","year":"2025","unstructured":"Wei J, Hui W, Fang Y, Jia H, Yang Y, Zhang T, et al. The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis. BMC Infect Dis. 2025;25:239.","journal-title":"BMC Infect Dis"},{"key":"7707_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101116","author":"J Bischoff","year":"2021","unstructured":"Bischoff J, Gu W, Schwarze-Zander C, Boesecke C, Wasmuth J-C, Van Bremen K, et al. Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART). EClinicalMedicine. 2021. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101116.","journal-title":"EClinicalMedicine"},{"key":"7707_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.athplu.2025.08.001","volume":"61","author":"AT Hirigo","year":"2025","unstructured":"HIRIGO AT, ABERA A, YILMA D, ASTATKIE A, DEBEBE Z. The association between dolutegravir based first-line antiretroviral regimens and dyslipidemia among adults living with HIV on follow-up at health facilities in Hawassa City administration, Sidama region: a cross-sectional study. Atheroscler Plus. 2025;61:48\u201357.","journal-title":"Atheroscler Plus"},{"key":"7707_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/20503121241260613","volume":"12","author":"M Jemal","year":"2024","unstructured":"Jemal M. A review of dolutegravir-associated weight gain and secondary metabolic comorbidities. SAGE Open Med. 2024;12:20503121241260613.","journal-title":"SAGE Open Med"},{"key":"7707_CR7","doi-asserted-by":"publisher","first-page":"6621097","DOI":"10.1155\/arat\/6621097","volume":"2025","author":"M Jemal","year":"2025","unstructured":"Jemal M, Adugna A. Dyslipidemia and its associated factors among people living with HIV on dolutegravir-based antiretroviral therapy at debre markos comprehensive specialized hospital, Northwest Ethiopia: a cross-sectional study. AIDS Res Treatment 2025;2025:6621097.","journal-title":"AIDS Res Treatment\u00a0"},{"key":"7707_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2295435","volume":"55","author":"M Jemal","year":"2023","unstructured":"Jemal M, Shibabaw Molla T, Tiruneh GMM, Chekol Abebe E, Asmamaw Dejenie T. Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study. Ann Med. 2023;55:2295435.","journal-title":"Ann Med"},{"key":"7707_CR9","doi-asserted-by":"publisher","first-page":"1506032","DOI":"10.3389\/fgstr.2025.1506032","volume":"4","author":"EM Sindato","year":"2025","unstructured":"Sindato EM, Kajogoo VD, Ngajilo G, Degu WA, Khan Z, Mlawa G. Prevalence and risk factors of metabolic-associated fatty liver disease in sub-Saharan Africa: a systematic review and meta-analysis. Front Gastroenterol. 2025;4:1506032.","journal-title":"Front Gastroenterol"},{"key":"7707_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/apt.17931","volume":"59","author":"R Enriquez","year":"2024","unstructured":"Enriquez R, Homsi M, Ssekubugu R, Nabukalu D, Zeebari Z, Marrone G, et al. Prevalence and risk factors of metabolic dysfunction-associated Steatotic liver disease in south Central Uganda: a cross\u2010sectional survey. Aliment Pharmacol Ther. 2024;59:1111\u201321.","journal-title":"Aliment Pharmacol Ther"},{"key":"7707_CR11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s12072-024-10706-1","volume":"18","author":"K Vaz","year":"2024","unstructured":"Vaz K, Kemp W, Majeed A, Lubel J, Magliano DJ, Glenister KM, et al. NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia. Hepatol Int. 2024;18:1135\u201343.","journal-title":"Hepatol Int"},{"key":"7707_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/cid\/ciae014","volume":"79","author":"MSR Weber","year":"2024","unstructured":"Weber MSR, Duran Ramirez J, Hentzien M, Cavassini M, Bernasconi E, Hofmann E, et al. Time trends in causes of death in people with HIV: insights from the Swiss HIV cohort study. Clin Infect Dis. 2024;79:177\u201388.","journal-title":"Clin Infect Dis"},{"key":"7707_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1098078","volume":"14","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Zhang Q, Li H, Zhou G, Shi P, Zhang X, et al. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease. Front Endocrinol. 2023;14:1098078.","journal-title":"Front Endocrinol"},{"key":"7707_CR14","doi-asserted-by":"publisher","first-page":"24847","DOI":"10.1038\/s41598-024-76002-y","volume":"14","author":"X Huang","year":"2024","unstructured":"HUANG X, LI J, ZHANG L, ZHANG C, LI C. The association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in US adults: a cross-sectional study. Sci Rep. 2024a;14:24847.","journal-title":"Sci Rep"},{"key":"7707_CR15","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.1113359108","volume":"108","author":"N Kumashiro","year":"2011","unstructured":"Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A. 2011;108:16381\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7707_CR16","doi-asserted-by":"crossref","unstructured":"Nzaramba, D., Bagenda, C. N., Mudondo, H., Tumusiime, J., Ssemwanga, E., Muhwezi, D., Lumumba, S. A., Kiconco, R., Rugera, S. P. & Mudondo SR, H. Low Aspartate aminotransferase\/alanine aminotransferase ratio as an indicator of metabolic syndrome among HIV patients on dolutegravir therapy in Southwestern Uganda. Cureus,\u00a02025;17.","DOI":"10.7759\/cureus.77166"},{"key":"7707_CR17","doi-asserted-by":"crossref","unstructured":"Wekesa C, Benson Kirkgdaizirej, Parkes-Ratanshi E-Mkarabarindea, R., Ocama P. Prevalence and factors associated with liver fibrosis among adult HIV-infected patients attending urban and rural care clinics in Uganda. Open Forum Infectious Diseases, 2020. Oxford University Press US, ofaa483.","DOI":"10.1093\/ofid\/ofaa483"},{"key":"7707_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"BEDOGNI G, BELLENTANI S, MIGLIOLI L, MASUTTI F, PASSALACQUA M, CASTIGLIONE A, TIRIBELLI C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006a;6:33.","journal-title":"BMC Gastroenterol"},{"key":"7707_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"BEDOGNI G, BELLENTANI S, MIGLIOLI L, MASUTTI F, PASSALACQUA M, CASTIGLIONE A, TIRIBELLI C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006b;6:1\u20137.","journal-title":"BMC Gastroenterol"},{"key":"7707_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-024-00197-2","volume":"10","author":"R Vamja","year":"2024","unstructured":"Vamja R, M Y, Vala V, Ramachandran A, Nagda J. Diagnostic accuracy of fatty liver index (FLI) for detecting metabolic associated fatty liver disease (MAFLD) in adults attending a tertiary care hospital, a cross-sectional study. Clin Diabetes Endocrinol. 2024;10:46.","journal-title":"Clin Diabetes Endocrinol"},{"key":"7707_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16788-x","volume":"12","author":"S Kang","year":"2022","unstructured":"Kang S, Kim E, Cho H, Kim DJ, Kim HC, Jung SJ. Associations between non-alcoholic fatty liver disease and cognitive impairment and the effect modification of inflammation. Sci Rep. 2022;12:12614.","journal-title":"Sci Rep"},{"key":"7707_CR22","unstructured":"Organization WH. Technical package for cardiovascular disease management in primary health care: team-based care. Technical package for cardiovascular disease management in primary health care: team-based care.\u00a02018."},{"key":"7707_CR23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, Larosa JC, Nestel PJ, et al. Association of LDL cholesterol, non\u2013HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307:1302\u20139.","journal-title":"JAMA"},{"key":"7707_CR24","first-page":"60","volume":"62","author":"\u0414 \u0414\u0440\u0432\u0438\u043b\u0430","year":"2022","unstructured":"\u0414\u0440\u0432\u0438\u043b\u0430 \u0414, \u0420\u043e\u0441\u0442\u043e\u0444\u0444 \u041f, \u041d\u0435\u0441\u0441\u043b\u0435\u0440 \u042f, \u041a\u043e\u043d\u0434\u0443\u0440\u0430\u0446\u043a\u0430\u044f \u0415. \u041f\u0440\u043e\u0433\u043d\u043e\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0437\u043d\u0430\u0447\u0435\u043d\u0438\u0435 \u043d\u0435\u0442\u0440\u0430\u0434\u0438\u0446\u0438\u043e\u043d\u043d\u044b\u0445 \u043f\u0430\u0440\u0430\u043c\u0435\u0442\u0440\u043e\u0432 \u043b\u0438\u043f\u0438\u0434\u043d\u043e\u0433\u043e \u043e\u0431\u043c\u0435\u043d\u0430: \u0438\u043d\u0434\u0435\u043a\u0441\u0430 \u0440\u0438\u0441\u043a\u0430 I \u043f\u043e \u041a\u0430\u0441\u0442\u0435\u043b\u043b\u0438, \u0438\u043d\u0434\u0435\u043a\u0441\u0430 \u0440\u0438\u0441\u043a\u0430 II \u043f\u043e \u041a\u0430\u0441\u0442\u0435\u043b\u043b\u0438 \u0438 \u043e\u0442\u043d\u043e\u0448\u0435\u043d\u0438\u044f \u0442\u0440\u0438\u0433\u043b\u0438\u0446\u0435\u0440\u0438\u0434\u043e\u0432 \u043a \u0445\u043e\u043b\u0435\u0441\u0442\u0435\u0440\u0438\u043d\u0443 \u043b\u0438\u043f\u043e\u043f\u0440\u043e\u0442\u0435\u0438\u043d\u043e\u0432 \u0432\u044b\u0441\u043e\u043a\u043e\u0439 \u043f\u043b\u043e\u0442\u043d\u043e\u0441\u0442\u0438 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0438\u043d\u0444\u0430\u0440\u043a\u0442\u043e\u043c \u043c\u0438\u043e\u043a\u0430\u0440\u0434\u0430 \u0431\u0435\u0437 \u043f\u043e\u0434\u044a\u0435\u043c\u0430 \u0441\u0435\u0433\u043c\u0435\u043d\u0442\u0430 ST \u043f\u0440\u0438 \u0433\u043e\u0434\u0438\u0447\u043d\u043e\u043c \u043d\u0430\u0431\u043b\u044e\u0434\u0435\u043d\u0438\u0438. \u041a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u044f. 2022;62:60\u20136.","journal-title":"\u041a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u044f"},{"key":"7707_CR25","doi-asserted-by":"publisher","first-page":"e0284697","DOI":"10.1371\/journal.pone.0284697","volume":"18","author":"NE Thomford","year":"2023","unstructured":"Thomford NE, Anyanful A, ATEKO RO, BLACKHURST D, BINEY RP, BOADI D, NYARKO SB, EKOR M, KYEI GB. Apolipoprotein E genetic variation, atherogenic index and cardiovascular disease risk assessment in an African population: an analysis of HIV and malaria patients in Ghana. PLoS One. 2023;18:e0284697.","journal-title":"PLoS One"},{"key":"7707_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","volume":"40","author":"PB Sandesara","year":"2019","unstructured":"Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40:537\u201357.","journal-title":"Endocr Rev"},{"key":"7707_CR27","volume":"13","author":"S Gao","year":"2020","unstructured":"Gao S, Ramen K, Yu S, Luo J. Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study. Int J Clin Exp Pathol. 2020;13:2569.","journal-title":"Int J Clin Exp Pathol"},{"key":"7707_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-0984-9","volume":"18","author":"XY Ren","year":"2019","unstructured":"Ren XY, Shi D, Ding J, Cheng ZY, Li HY, Li JS, et al. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study. Lipids Health Dis. 2019;18:47.","journal-title":"Lipids Health Dis"},{"key":"7707_CR29","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","volume":"394","author":"FJ Brunner","year":"2019","unstructured":"Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019;394:2173\u201383.","journal-title":"Lancet"},{"key":"7707_CR30","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75:3313\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"7707_CR31","doi-asserted-by":"publisher","first-page":"1457589","DOI":"10.3389\/fendo.2024.1457589","volume":"15","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, Zhu M, Xu L, Huangfu S, Li T, Liu C, Zhou D. Elevated non-HDL-C to HDL-C ratio as a marker for NAFLD and liver fibrosis risk: a cross-sectional analysis. Front Endocrinol (Lausanne). 2024;15:1457589.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7707_CR32","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1111\/liv.12318","volume":"34","author":"S Zelber-Sagi","year":"2014","unstructured":"Zelber-Sagi S, Salomone F, Yeshua H, Lotan R, Webb M, Halpern Z, et al. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease. Liver Int. 2014;34:e128-35.","journal-title":"Liver Int"},{"key":"7707_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04291-4","volume":"21","author":"JH Lee","year":"2023","unstructured":"Lee JH, Kim J, Kim JO, Kwon YJ. Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study. J Transl Med. 2023;21:435.","journal-title":"J Transl Med"},{"key":"7707_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104392","author":"I Ayada","year":"2023","unstructured":"Ayada I, Van Kleef LA, Zhang H, Liu K, Li P, Abozaid YJ, et al. Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study. EBioMedicine. 2023. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104392.","journal-title":"EBioMedicine"},{"key":"7707_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40200-025-01719-0","volume":"24","author":"S Esmaeili","year":"2025","unstructured":"Esmaeili S, Shafiee A, Ataie-Jafari A, Semnani K, Goodarzi S, Mahdavi-Gorabi A, Qorbani M. Non-HDL-C and non-HDL-C\/HDL-C ratio as predictors of hepatic steatosis: a systematic review and meta-analysis. J Diabetes Metabolic Disorders. 2025;24:1\u201316.","journal-title":"J Diabetes Metabolic Disorders"},{"key":"7707_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0720-x","volume":"17","author":"D Wang","year":"2018","unstructured":"Wang D, Wang L, Wang Z, Chen S, Ni Y, Jiang D. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids Health Dis. 2018;17:67.","journal-title":"Lipids Health Dis"},{"key":"7707_CR37","doi-asserted-by":"publisher","first-page":"1457589","DOI":"10.3389\/fendo.2024.1457589","volume":"15","author":"Y Xuan","year":"2024","unstructured":"XUAN Y, ZHU M, XU L, HUANGFU S, LI T, LIU C, ZHOU D. Elevated non-HDL-C to HDL-C ratio as a marker for NAFLD and liver fibrosis risk: a cross-sectional analysis. Front Endocrinol. 2024b;15:1457589.","journal-title":"Front Endocrinol"},{"key":"7707_CR38","doi-asserted-by":"publisher","first-page":"1557751","DOI":"10.3389\/fnut.2025.1557751","volume":"12","author":"D Yang","year":"2025","unstructured":"Yang D, Dai H, Zhang Wangy, Wei J, Shan M, Zhang X. Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease. Front Nutr. 2025;12:1557751.","journal-title":"Front Nutr"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07707-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07707-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07707-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:24:15Z","timestamp":1774614255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07707-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7707"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07707-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Research Ethics Committee (REC) of the Mbarara University of Science and Technology (REC number: MUST-2024-1575) on 10 June 2024 to conduct the primary study [\n                      \n                      ]. All participants provided written informed consent prior to enrollment. The consent forms were translated into the local language (Runyankore) to ensure comprehension. Formally educated participants gave consent by signing the written forms. For participants with no formal education, the written informed consent form was read aloud in Runyankore, followed by administration of the comprehension screening tool approved by the MUST REC. Only participants who demonstrated understanding were allowed to consent by placing a thumbprint on the informed consent form. Participants were also explicitly asked to provide consent for the use of their data in the secondary analysis, for which they approved. This study was conducted in accordance with the Declaration of Helsinki (1975) as revised in 2024. Confidentiality of the study participants was observed by giving each participant a study code that was not traceable to them. To protect patient privacy, all personal identifiers were removed, and the data were fully deidentified before analysis. Permission to perform secondary analysis was also obtained from the principal investigator of the primary study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}